Bohui Bio

About:

Bohui Bio is an immune disease research and development company.

Website: http://www.broadenbio.com/

Top Investors: Tao Capital

Description:

Bohui Bio is a biotech company that engages in the clinical stage of drug research and development. Senior medication research and development professionals from pharmaceutical firms who returned to the neighborhood and focused on tumors and autoimmune illnesses helped co-found the organization. The company is dedicated to the development of global medications and has established a variety of research and development pipelines for unmet clinical requirements through the research and development strategy. The company has developed an immune function detection platform and a molecular coupling technology platform with the assistance of numerous reputable investment institutions in the sector.

Total Funding Amount:

10M CNY

Headquarters Location:

Daxing, Beijing, China

Founded Date:

2018-03-01

Contact Email:

hr(AT)broadenbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-04-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai